Quantcast

Latest Biomarker Stories

2014-10-02 08:30:10

MENLO PARK, Calif., Oct. 2, 2014 /PRNewswire/ -- 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious diseases, will present clinical data for its lead therapeutic compound, TVB-2640, in a late-breaking oral session at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics on November 18 - 21, 2014, in Barcelona, Spain....

2014-10-02 08:28:50

Results, Published in Clinical Genitourinary Cancer, Offer Key Insights and Potential New Treatment Strategies for Patient Population with Limited Drug Options IRVING, Texas, Oct. 2, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced the publication of a study in which Caris Molecular Intelligence(TM), the company's comprehensive tumor profiling service, was used to identify actionable biomarkers in...

2014-09-30 23:08:17

Life Length, the world leader in telomere analysis, is pleased to add Cleveland HeartLab to their current list of partner labs from across the globe. Madrid, Spain and Cleveland, Ohio (PRWEB) September 30, 2014 Life Length and Cleveland HeartLab (CHL) announce a new agreement which provides CHL access to Life Length’s proprietary Telomere Analysis Technology™ (TATTM). Life Length offers the most advanced and comprehensive telomere test on the market today, and is the only...

2014-09-30 08:29:03

NEW YORK, Sept. 30, 2014 /PRNewswire/ -- Proteomics is a focus point for investment and collaboration, according to a new report from Kalorama Information. The healthcare market research publisher said that over 100 deals had occurred in proteomics in the past two years. The activity ranges from investments and IPOs, to agreements between private proteomic companies and academic institutions, to deals between pharma and biotech companies with novel proteomics innovator companies. Kalorama...

2014-09-26 08:25:19

DUBLIN, Sept. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 This report is a comprehensive analysis and market study of the drug development pipeline relating to Alzheimer's Disease, which has been analysed alongside commercially available or developmental...

2014-09-25 12:27:54

NEW YORK, Sept. 25, 2014 /PRNewswire/ -- The market for "proteomics" instruments, reagents and testing for research and diagnostic applications topped 5 billion dollars in 2013, and should see rapid revenue growth, according to Kalorama information. The healthcare market research publisher said demand for better understanding of proteins and a desire for new therapies is expected to continue to grow the proteomics market rapidly, despite cost pressures generally in research. The...

2014-09-23 23:02:21

OMICS Group International is elated to launch its 4th International Conference and Exhibition on Metabolomics and Systems Biology during April 27-29, 2015 at Philadelphia, USA, focusing on the theme “Metabolomics Technology and Omics Sciences - A Roadmap for Advanced Research Initiatives” Los Angeles, CA (PRWEB) September 23, 2014 Speaking on this occasion, Dr. Vladimir Bondarenko said “Organizing Committee for Metabolomics-2015 welcomes industrial and academic researchers to attend...

2014-09-23 16:27:31

IRVINE, Calif., Sept. 23, 2014 /PRNewswire/ -- Global Discovery Biosciences, a laboratory dedicated to leveraging research and technology to conquer some of the biggest healthcare challenges, announces their collaboration with IPMD, Inc. to develop a simple and highly accurate blood test for the early detection of lung cancer. Lung cancer is the leading cause of cancer death. Typically, the symptoms and subsequent diagnosis of lung cancer appear at an advanced stage of cancer, where the...

2014-09-19 23:08:36

SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit specializing in complex early-phase trials, announced today the successful completion of a validation study of the NeuroCart. The study validated the NeuroCart as an effective tool for detection of benzodiazepine-evoked pharmacodynamic CNS effects. Baltimore, MD (PRWEB) September 19, 2014 SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit...

2014-09-19 23:04:17

GIA announces the release of a comprehensive global report on Immunoassay Systems. Global market for Immunoassay Systems is projected to reach US$17.9 billion by 2020, driven by aging population, rise in chronic & infectious diseases, development of novel biomarkers, robust demand for non-invasive diagnostic tools, and improved access to healthcare & testing services in developing countries. San Jose, California (PRWEB) September 19, 2014 Follow us on LinkedIn – Immunoassays are...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related